Figures & data
Table 1 Patients background
Figure 1 Kaplan–Meier curve of post-metastatic survival in bone or soft-tissue sarcoma patients (n=48) treated with metastasectomy and/or radiofrequency ablation of the lung.
![Figure 1 Kaplan–Meier curve of post-metastatic survival in bone or soft-tissue sarcoma patients (n=48) treated with metastasectomy and/or radiofrequency ablation of the lung.](/cms/asset/0fe22609-c864-41fc-8f85-a6f8d66975de/dott_a_12195387_f0001_b.jpg)
Table 2 Univariate analysis for survival
Table 3 Multivariate analysis for survival
Table 4 Predictive factors which related with curability
Figure 2 Kaplan–Meier curves of post-metastatic survival in bone or soft-tissue sarcoma patients (n=48) with (A) complete treatment and a tumor volume doubling time (TVDT) of >30 days, (B) incomplete treatment and a TVDT of >30 days, (C) complete treatment and a TVDT of ≤30 days, and (D) incomplete treatment and a TVDT of ≤30 days.
![Figure 2 Kaplan–Meier curves of post-metastatic survival in bone or soft-tissue sarcoma patients (n=48) with (A) complete treatment and a tumor volume doubling time (TVDT) of >30 days, (B) incomplete treatment and a TVDT of >30 days, (C) complete treatment and a TVDT of ≤30 days, and (D) incomplete treatment and a TVDT of ≤30 days.](/cms/asset/ebba4b63-3309-4cac-85dd-35503f3b2a86/dott_a_12195387_f0002_b.jpg)